Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 2 Compare versions History 4 Sponsors

A6927A — · 476 words Open full page ↗

STATE OF NEW YORK

________________________________________________________________________

6927--A

2025-2026 Regular Sessions

IN ASSEMBLY

March 18, 2025

___________

Introduced by M. of A. SIMONE, TAPIA, GONZALEZ-ROJAS, REYES, SHIMSKY,

Sign in to read the full text

The document summary and details above are public. The full text is available to signed-in accounts.

Create a free account Sign in

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base Amended — base rate 13%, measured from NY's completed sessions
Momentum +2 58/100 from the pace of recorded action
Time since last action -19 138 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.